Moreover, both Alzheimer’s and Parkinson’s disease patients and animal models displayed diminished Nurr1 expression, and low Nurr1 levels were found, for example, to enhance susceptibility of neurons to α-synuclein induced damage13–15. Here, NR4A2 is linked to Parkinson disease.